Document Detail


Bone mineral density and risk of postmenopausal breast cancer.
MedLine Citation:
PMID:  20838879     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
To determine if higher bone mineral density (BMD) is a risk factor for breast cancer in women age 50 years and older. 37,860 women ≥50-year old with no previous breast cancer diagnosis had baseline BMD assessment between January 1999 and December 2007. Cox proportional hazards models were created for time to a new breast cancer as a function of lumbar spine or femoral neck BMD quartile (1st = lowest as reference) with adjustment for relevant covariates. A secondary analysis was performed to look for an association with estrogen receptor-positive (ER-positive) breast cancers. 794 invasive and in situ breast cancers (484 ER-positive) occurred with a median follow up of 5.4 years. Increased breast cancer risk was seen for the 3rd and 4th quartiles of lumbar spine BMD with hazard ratios (HRs) of 1.26 (95% CI, 1.01-1.58) and 1.45 (95% CI, 1.16-1.81), respectively and for the 3rd quartile of femoral neck BMD with a HR of 1.33 (95% CI, 1.07-1.64). A test for linear trend showed that lumbar spine BMD (P < 0.001) and femoral neck BMD (P = 0.04) were associated with increased risk. Higher lumbar spine BMD was also associated with increased risk of ER-positive breast cancer with HR of 1.45 (95% CI, 1.08-1.94), and 1.68 (95% CI, 1.24-2.27) for women in the 2nd and 4th quartiles, respectively. A test for linear trend showed lumbar spine BMD was associated with increasing risk of ER-positive breast cancer (P = 0.003). Increased ER-positive breast cancer risk was seen for the 3rd quartile of femoral neck BMD with a HR of 1.43 (95% CI, 1.08-1.89). Higher lumbar spine and femoral neck BMD are associated with higher risk of breast cancer in women ≥50-year old. Lumbar spine and femoral neck BMD are associated with increased risk of ER-positive breast cancer.
Authors:
Debjani Grenier; Andrew L Cooke; Lisa Lix; Colleen Metge; Huimin Lu; William D Leslie
Related Documents :
6956759 - Interaction of familial and hormonal risk factors for breast cancer.
22901129 - Sirna mediated silencing of nin1/rpn12 binding protein 1 homolog inhibits proliferation...
12131659 - Risk factors for male breast cancer in canada, 1994-1998.
22431919 - Regulation of p130(cas)/bcar1 expression in tamoxifen-sensitive and tamoxifen-resistant...
18411579 - Desire for a child and breast cancer.
22346359 - Clinico-pathological characteristics of triple negative and non triple negative high gr...
24247619 - Prohibitin expression is associated with high grade breast cancer but is not a driver o...
7434309 - Elastic recoil changes in early emphysema.
1707989 - Prostate specific antigen: a critical assessment of the most useful tumor marker for ad...
Publication Detail:
Type:  Journal Article     Date:  2010-09-14
Journal Detail:
Title:  Breast cancer research and treatment     Volume:  126     ISSN:  1573-7217     ISO Abbreviation:  Breast Cancer Res. Treat.     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8111104     Medline TA:  Breast Cancer Res Treat     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  679-86     Citation Subset:  IM    
Affiliation:
CancerCare Manitoba, 675 McDermot, Avenue, Winnipeg, MB, R3E 0V9, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas.
Next Document:  A critical time for medical education: the perils of competence-based reform of the curriculum.